Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
15.91
-0.05 (-0.31%)
At close: Nov 20, 2024, 4:00 PM
14.25
-1.66 (-10.43%)
After-hours: Nov 20, 2024, 7:59 PM EST
Kura Oncology Employees
Kura Oncology had 142 employees as of December 31, 2023. The number of employees increased by 9 or 6.77% compared to the previous year.
Employees
142
Change (1Y)
9
Growth (1Y)
6.77%
Revenue / Employee
n/a
Profits / Employee
-$1,391,211
Market Cap
1.24B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pediatrix Medical Group | 5,450 |
Novavax | 1,543 |
Indivior | 1,164 |
STAAR Surgical Company | 1,057 |
Rocket Pharmaceuticals | 268 |
Innoviva | 112 |
Mesoblast | 73 |
Enliven Therapeutics | 46 |
KURA News
- 10 hours ago - Kura Oncology to partner with Kyowa Kirin for blood cancer therapy - Reuters
- 10 hours ago - Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias - GlobeNewsWire
- 11 days ago - Kura Oncology, Inc. (KURA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting - GlobeNewsWire
- 20 days ago - Kura Oncology to Report Third Quarter 2024 Financial Results - GlobeNewsWire
- 22 days ago - Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors - Business Wire
- 27 days ago - Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST) - GlobeNewsWire
- 4 weeks ago - Kura Oncology to Present New Data Supporting Combination of KO-2806 with KRAS G12C and Pan-RAS Inhibitors - GlobeNewsWire